Interestingly, anti-O-acetyl-GD2 antibody therapy enhanced CD47 expression on tumor cells and induced influx of F4/80+ macrophages in a NXS2 liver metastasis model, which further explains the synergy of anti-GD2 and anti-CD47 therapy. The gene discussed is CD47; the disease is neoplasm.